Lymphomatoid papulosis: response to treatment with recombinant interferon alfa-2b

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.

Blood cancer journal·2024

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

Leukemia·2017

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

Blood cancer journal·2017

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial.

Blood cancer journal·2016

Genetic factors influencing the risk of multiple myeloma bone disease.

Leukemia·2015

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.

Leukemia·2011

Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

The Patient Who Could Not Die.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Genital Herpes in an HIV-Positive Patient Mimicking Donovanosis: A Case Report.

Cureus·2026

Olfactory Hallucinations as the Initial Symptom of Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis: A Case Report and Review of the Literature.

Cureus·2026

Oral lichen planus possibly associated with Hashimoto's thyroiditis: A case-control study in a northwest Chinese population.

Journal of dental sciences·2026

Gastric parietal cell and thyroid autoantibodies in patients with oral lichen planus.

Journal of dental sciences·2026

Apolipoprotein L1 risk genotypes and odds of lupus nephritis-associated kidney failure in systemic lupus erythematosus: a systematic review and meta-analysis.

Frontiers in medicine·2026

Decoding Treg diversity and dysfunction to advance Treg-based therapies in autoimmune and inflammatory diseases.

Frontiers in immunology·2026

Related Experiment Videos

Lymphomatoid papulosis: response to treatment with recombinant interferon alfa-2b

Related Concept Videos

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial.

Genetic factors influencing the risk of multiple myeloma bone disease.

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.

Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.

Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.

The Patient Who Could Not Die.

Genital Herpes in an HIV-Positive Patient Mimicking Donovanosis: A Case Report.

Olfactory Hallucinations as the Initial Symptom of Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis: A Case Report and Review of the Literature.

Oral lichen planus possibly associated with Hashimoto's thyroiditis: A case-control study in a northwest Chinese population.

Gastric parietal cell and thyroid autoantibodies in patients with oral lichen planus.

Apolipoprotein L1 risk genotypes and odds of lupus nephritis-associated kidney failure in systemic lupus erythematosus: a systematic review and meta-analysis.

Decoding Treg diversity and dysfunction to advance Treg-based therapies in autoimmune and inflammatory diseases.

Related Experiment Videos

Lymphomatoid papulosis: response to treatment with recombinant interferon alfa-2b

Related Concept Videos

Related Articles